Vistin Pharma ASA (OSL:VISTN)

Market Cap	1.04B
Revenue (ttm)	452.25M
Net Income (ttm)	76.10M
Shares Out	44.34M
EPS (ttm)	1.72
PE Ratio	13.64
Forward PE	n/a
Dividend	1.25 (5.34%)
Ex-Dividend Date	Jun 4, 2025

Volume	3,816
Average Volume	24,200
Open	23.10
Previous Close	23.40
Day's Range	23.10 - 23.40
52-Week Range	22.10 - 28.80
Beta	0.63
RSI	39.97
Earnings Date	Aug 15, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 75
• Stock Exchange: Oslo Børs
• Ticker Symbol: VISTN

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.